Riverhead Capital Management’s Globus Medical GMED Stock Holding History

Riverhead Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$538K	Hold	10,522	–	–	0.02%	695
2019 Q2	$445K	Hold	10,522	–	–	0.02%	771
2019 Q1	$520K	Hold	10,522	–	–	0.02%	694
2018 Q4	$455K	Hold	10,522	–	–	0.02%	694
2018 Q3	$597K	Buy	10,522 +2,000	+23%	+$105K	0.02%	670
2018 Q2	$430K	Hold	8,522	–	–	0.02%	736
2018 Q1	$424K	Hold	8,522	–	–	0.02%	720
2017 Q4	$350K	Buy	8,522 +1,300	+18%	+$45.5K	0.01%	817
2017 Q3	$215K	Buy	7,222 +861	+14%	+$26.3K	0.01%	964
2017 Q2	$211K	Buy	6,361 +2,961	+87%	+$93K	0.01%	892
2017 Q1	$101K	Buy	+3,400	New	+$92.8K	0.01%	1002

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Riverhead Capital Management's GMED Position: Q3 2019 in Review

Riverhead Capital Management held its Globus Medical (GMED) position steady in Q3 2019 at 10,522 shares worth $538K. The position accounts for 0.02% of the portfolio, ranked #695.

Riverhead Capital Management first reported a position in GMED in Q1 2017 and has held it in 11 quarters since. The position peaked at $597K in Q3 2018. 268 funds tracked by Wall St. Rank hold GMED as of Q3 2019.

Riverhead Capital Management held 10,522 shares of Globus Medical worth $538K as of Q3 2019.
Riverhead Capital Management left its Globus Medical share count unchanged in Q3 2019.
Globus Medical made up 0.02% of Riverhead Capital Management's portfolio in Q3 2019, its #695 holding.
Riverhead Capital Management first reported a position in Globus Medical in Q1 2017 and has held it in 11 quarters since.
Riverhead Capital Management's Globus Medical position peaked at $597K in Q3 2018.
268 funds tracked by Wall St. Rank held Globus Medical as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.